The document discusses strategies for pharmaceutical companies to effectively engage with women consumers. It notes that women represent a substantial healthcare market, with more than 700 medicines currently in development for diseases that affect women. It recommends focusing on credibility, charisma, customization, and community to build brand attachment. Successful engagement relies on understanding women's health concerns and providing a dialogue through various media channels to attract their attention and gain their adoption, advocacy, and trust to "woo and win" them as brand advocates.